Behavioral Health Integration: Screening and Identification
description
Transcript of Behavioral Health Integration: Screening and Identification
Behavioral Health Integration:
Screening and IdentificationNeil Korsen, MD, MSc
Quality CountsApril 11, 2012
Outline
Identifying patients who may benefit from behavioral health integration:– Screening for common behavioral health problems
Depression Anxiety disorders Substance use disorders
– Supporting health behavior change for chronic illness care
– Evaluation and treatment of common symptoms such as headache, fatigue, other pain syndromes that are often associated with psychosocial factors.
Screening for Depression
High risk populations
People with chronic illnesses or chronic pain
People with a disability People with substance abuse problems Kids with school, sleep or behavior
problems People with persistent somatic complaints
and negative workup
PATIENT QUESTIONNAIRE (PHQ-9)
Name: Date: Over the last 2 weeks, how often have you been bothered by any of the following problems? (use “ ” to indicate your answer)
Not at all Several
days
More than half the days
Nearly every day
1. Little interest or pleasure in doing things 0 1 2 3
2. Feeling down, depressed, or hopeless 0 1 2 3
3. Trouble falling/staying asleep, sleeping too much 0 1 2 3
4. Feeling tired or having little energy 0 1 2 3
5. Poor appetite or overeating 0 1 2 3
6. Feeling bad about yourself – or that you are a failure or have let yourself or your family down 0 1 2 3
7. Trouble concentrating on things, such as reading the newspaper or watching television 0 1 2 3
8. Moving or speaking so slowly that other people could have noticed. Or the opposite – being so fidgety or restless that you have been moving around a lot more than usual
0 1 2 3
9. Thoughts that you would be better off dead, or of hurting yourself in some way. 0 1 2 3
Add Columns: _____ + _____ + _____
(Healthcare professional: For interpretation TOTAL: of TOTAL, please refer to back of page) _______
Not difficult at all _______
Somewhat difficult _______
Very difficult _______
If you checked off any problem on this questionnaire so far, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?
Extremely difficult _______
Patient Health Questionnaire (PHQ) Copyright© 1999 Pfizer Inc. All rights reserved. Reproduced with
permission. PRIME-MD ® is a trademark of Pfizer Inc.
Scoring the PHQ-9
First 9 questions: add columns vertically, then tally across bottom of page
Total score: 0 to 27 10th question is “Function Score”: what degree
depression symptoms have made it difficult for the patient to function in their everyday life
Degree of functional difficulty can help determine whether to start active treatment in people with mild symptoms.
Guideline: Initial Management & Follow-upScore/
Symptom Level
Treatment Follow-up PHQ-9
0-4No
depression
Consider other diagnoses (Annual screen with chronic conditions or depression hx)
5-9Mild
Consider other diagnosesIf diagnosis is depression, watchful waiting is appropriate initial management
12 months
10-14Moderate
Consider watchful waitingIf active treatment is needed, medication or psychotherapy is equally effective; consider function score in choosing treatment
3 - 6 months
15-19Moderately
Severe
Active treatment with medication or psychotherapy is recommendedMedication or psychotherapy is equally effective
1 – 3 months
20-27Severe
Medication treatment is recommended For many people, psychotherapy is useful as an additional treatmentPeople with severe symptoms often benefit from consultation with a psychiatrist
1 – 3 months
What is Watchful Waiting? Est. 1/3 with mild symptoms will recover
without treatment. Watchful waiting:
– Seeing pt monthly and monitoring PHQ-9 score, but not starting active treatment.
– Encourage self-care activities such as exercise or relaxation.
If symptoms have not resolved after 2-3 mos, consider active treatment.
PHQ-9 as Outcome Measure Can be used to follow response to
treatment Validated as a measure of change
and can be used to create an algorithm to guide treatment decisions
PHQ-9 - Change from last score, measured monthly
TreatmentResponse
Treatment Plan
Drop of 5 or more points each month
Good Antidepressant &/or PsychotherapyNo treatment change needed. Follow-up in 4 weeks.
Drop of 2-4 points each month
Fair Antidepressant: May warrant an increase in dose.Psychotherapy: Probably no treatment change needed.
Share PHQ-9 with psychotherapist.Drop of 1 point, no change or
increase each monthPoor Antidepressant: Increase dose or
augment or switch; informal or formal psychiatric consult; add psychotherapy.
Psychotherapy: 1. If depression-specific psychotherapy
discuss with supervising psychiatrist, consider adding antidepressant.
2. For patients satisfied in other psychotherapy consider adding antidepressant.
3. For patients dissatisfied in other psychotherapy, review treatment options and preferences.
Interpreting Follow Up Scores
Goals of Treatment Remission: score of 0-4 after an
initial score >10 Clinical response: score <10 after an
initial score >10
Screening for Anxiety Disorders
Anxiety Disorders Anxiety disorders often accompany
depression. Common anxiety disorders include:
Generalized anxiety disorder (GAD)
Panic disorder Post–traumatic stress disorder (PTSD) Social phobia
Anxiety Disorders Very common
30% lifetime prevalence in women 20% lifetime prevalence in men
Often present with physical symptoms to primary care
GAD-7 - Scoring
GAD-7 Score
Symptoms Treatment Recommendations
5-9 Mild Watchful waiting
10-14 Moderate Psychotherapy – first line of treatment
>15 Severe Medication and/or psychotherapy
NICE Treatment Guidelines
Step 1 ID & assessment; education about GAD and tx options; active monitoring
Step 2 Low-intensity psychological interventions: non-facilitated or guided self-help, psycho-ed groups
Step 3 High-intensity psychological intervention: CBT/ applied relaxation or drug treatment
Step 4 Specialty treatment: drug and/or psychological treatment; input from multi-agency teams,
crisis services, day hospitals or inpatient care http://guidance.nice.org.uk/
Screening for Substance Use Disorders
Substance use disorders
An estimated 17.6 million American adults (8.5%) meet diagnostic criteria for an alcohol use disorder.
Approximately 4.2 million (2%) meet criteria for a drug use disorder.
Overall, 19.4 million of American adults (9.4%) meet clinical criteria for a substance use disorder - either an alcohol or drug use disorder or both.
About 20% of persons with a current substance use disorder experience a mood or anxiety disorder at the same time and vice versa.
MaineHealth Adult Wellbeing Screener – Substance Abuse
Question 7 is recommended by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). The single-question screen was 81.8% sensitive and 79.3% specific in the detection of unhealthy alcohol use.*
Question 8 was found to be 100% sensitive and 74% specific for identifying people with a drug use disorder in a 2007 study.
A “yes” answer to either question 7 or 8 is a positive screen for substance abuse.**
During the past year: No Yes7. Have you had 4 or more drinks (women) / 5 or more drinks (men) in a
day?
8. Have you used an illegal drug or used a prescription drug for a non-medical reason?
*Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. J Gen Intern Med 2009 **Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Arch Int Med 2010
Further Assessment after Positive Screen
Adults – alcohol AC-OK AUDIT CAGE
Adults – other drugs DAST
Adolescents CRAFFT
SAMHSA list of substance screening and assessment instruments:http://www.ncsacw.samhsa.gov/files/SAFERR_AppendixD.pdf
Implementing Screening
A script for the person distributing the tools Who will score forms and when? How will assessment follow screening? How will results get documented?
Consider a daily huddle:
Role of Behavioral Health Clinician with Chronic Medical Conditions
Chronic condition management involves self-management
Self-management involves behavior change
Behavioral health clinicians can play a role in supporting behavior change– Use of health and behavior codes
Impact of Integration on Outcomes of Chronic Medical Conditions
Improved outcomes for both medical and co-morbid mental health conditions
Improved patient experience Cost impact may be neutral or show
slight savings– E. Lin, personal communication, 2012
Integration and Common Physical Symptoms
Estimates range from 25-75% of people with common symptoms such as headache, other pain syndromes, and fatigue have no ‘medical’ cause found after reasonable evaluation (Kroenke, 2003)
Emerging literature that past or present psychosocial stress and/or common behavioral health conditions are commonly associated with these symptoms
Screening and Assessment ToolsScoring and Treatment Guidelines
Tools and guides to treatment posted: www.mainehealth.org/mentalhealthintegration
Located in Links under Clinical Tools
References Kroenke K, et al. Anxiety Disorders in Primary Care: Prevalence,
Impairment, Comorbidity, and Detection. Ann Intern Med. 2007;146:317-325.
Kroenke K, Patients Presenting with Somatic Complaints. International Journal of Methods in Psychiatric Research. 2003; 12: 34-43.
Kroenke, Spitzer, and Williams. The PHQ-9: Validation of a Brief Depression Severity Measure. Journal of General Internal Medicine. 2001; 16:606-613.
Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary Care Validation of a Single-Question Alcohol Screening Test. J Gen Intern Med 2009; 24:783-788
Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A Single Question Screening Test for Drug Use in Primary Care. Archives of Internal Medicine 2010; 170:1155-1160